Dizziness, a common complaint in clinical practice, often presents diagnostic challenges due to its multifactorial nature. Vertigo, a subtype of dizziness, is characterized by a sensation of self-motion or environmental movement, often associated with balance disorders.
Vertigo can be divided into peripheral and central types, based on the location of the lesion. Peripheral vertigo, the most common type, originates from the inner ear or vestibular nerve, while central vertigo arises from the central nervous system. Differentiating between these types is crucial for effective management.
The initial approach to vertigo involves a thorough history and physical examination, including a neurological exam. Key features such as onset, duration, triggers, and associated symptoms can help narrow the differential diagnosis. Nystagmus, a clinical sign of vertigo, should be assessed as it can provide clues about the underlying pathology.
While clinical evaluation forms the cornerstone of vertigo diagnosis, certain cases may require further testing. Imaging studies, such as MRI or CT scans, may be indicated in central vertigo or if there is suspicion of a structural lesion. Vestibular function tests, like electronystagmography and videonystagmography, can aid in diagnosing peripheral vertigo.
Treatment of vertigo is tailored to the underlying cause. Peripheral vertigo is often managed with vestibular suppressants, while central vertigo may require treatment of the underlying neurological condition. Vestibular rehabilitation therapy is a useful adjunct in managing chronic or recurrent vertigo.
Vertigo is a complex clinical entity that requires a systematic approach for effective management. Understanding the clinical spectrum, utilizing a comprehensive diagnostic approach, and tailoring treatment strategies to the underlying cause are key to improving patient outcomes.
1.
Extracellular matrix pathway emerges as treatment target for pediatric cancer
2.
Researchers explore e-bikes for cancer recovery
3.
According to new studies, some cancer patients can safely forego radiation therapy.
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
A single bout of exercise gives results that could help cancer patients
1.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
2.
Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication
3.
Clonal Hematopoiesis and Healthy Aging: Insights, Mechanisms, and Clinical Relevance
4.
Clinical Guidance for Survivorship-Focused Cancer Care
5.
Bone Marrow Regenerative Capacity and Hematologic Recovery
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Recognizing Symptoms of Vitamin B12 Deficiency
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation